CSX
41
-10
TROW
56
-2
MAR
53
-6
RCL
59
-3
TDC
83
3
ADSK
62
-4
PVH
39
-5
BBY
38
-12
PG
48
-5
ETN
67
2
HSY
34
-3
EBAY
52
5
AMT
38
4
VIX
43
8
K
60
6
KMI
55
-8
IR
63
3
SYK
40
-6
SIG
47
3
MCO
62
-5
CSX
41
-10
TROW
56
-2
MAR
53
-6
RCL
59
-3
TDC
83
3
ADSK
62
-4
PVH
39
-5
BBY
38
-12
PG
48
-5
ETN
67
2
HSY
34
-3
EBAY
52
5
AMT
38
4
VIX
43
8
K
60
6
KMI
55
-8
IR
63
3
SYK
40
-6
SIG
47
3
MCO
62
-5
Financhill
Back

Cleveland-Cliffs, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
36

CLF
Cleveland-Cliffs, Inc.

Last Price:
$12.37
Seasonality Move:
8.94%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
36
Cleveland-Cliffs, Inc. (CLF) is a Sell

Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?

  • The current Cleveland-Cliffs, Inc. [CLF] share price is $12.37. The Score for CLF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CLF Stock Price Chart

What is Cleveland-Cliffs, Inc.'s stock price today?

  • The Cleveland-Cliffs, Inc. share price today is $12.37
    The current trend is moderately bullish and CLF is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

CLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 52.75 Buy
Chaikin Money Flow: 7323511 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.55 - 12.51) Buy
Bollinger Bands (100): (10.27 - 12.95) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

CLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.73 Sell
20-day SMA: 11.73 Buy
50-day SMA: 12.44 Sell
200-day SMA: 9.92 Buy
8-day EMA: 12.47 Sell
20-day EMA: 12.17 Buy
50-day EMA: 11.99 Buy
200-day EMA: 11.09 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.72 per share, and an increase next year of $2.66 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Cleveland-Cliffs, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):